ClinicalTrials.gg
CompletedNCT00746187Updated Apr 13, 2016Results posted

Study to Compare Marginal Bone Loss Around Implants From Two Dental Implant Systems.

An interventional study of ASTRA TECH Implant System; Fixture ST: Ø 4.5 cm in lengths of 9, 11 and 13 mm. and 3i Osseotite® implant: Ø 4.0 in lengths of 8.5, 10, 11.5 and 13 mm in Jaw, Edentulous, Partially, sponsored by Dentsply Sirona Implants and Consumables. Completed at 2 sites in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2016-04-13.

Sponsored by Dentsply Sirona Implants and Consumables (part of Dentsply Sirona) · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 18 studies in Jaw, Edentulous, Partially by Dentsply Sirona — none open to participants now, 2 under way, none of them phase 3. Jaw, Edentulous, Partially · Dentsply Sirona.

Enrollment
17th of 18
36 · median 60
Started
2002
the only one that year
No phase
18 of 18
none open now
Registered
7th of 18
by date

Among the 18 studies in Jaw, Edentulous, Partially by Dentsply Sirona, this one is the 17th largest by enrollment, is the only one that started in 2002, is one of 18 with no phase, and was the 7th registered.

Jaw, Edentulous, Partially

76 studies on the registry are indexed under Jaw, Edentulous, Partially; 7 are open to participants now.

Browse Jaw, Edentulous, Partially studies →

Open to participants now

None of the 18 studies in Jaw, Edentulous, Partially by Dentsply Sirona is open now. The open studies under Jaw, Edentulous, Partially, anywhere →

Who these studies take

Of the 6 Jaw, Edentulous, Partially studies recruiting now, 4 set no upper age limit and 1 stops at 75 or younger; none take children under 18; 2 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 18 studies in Jaw, Edentulous, Partially by Dentsply Sirona as a file.
02

Study summary

The purpose of this study is to compare marginal bone level changes between ASTRA TECH Implant System; Fixture ST and Biomet 3i; Osseotite® Implants. Subjects with partial edentulism in the posterior maxilla and/or mandible will be included and a one-stage surgical protocol will be used. Implants will be loaded within 15 weeks from installation. The subjects will be followed for 3 years.

03

Conditions studied

  • Jaw, Edentulous, Partially
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Provision of written
  • Age 18 - 75 years
  • Partial edentulism, Kennedy class I or II, last natural tooth must be cuspid or first bicuspid
  • Edentulous in the area/s if implant placement for more than 2 months

Exclusion criteria

Exclusion Criteria:

  • Untreated caries and/or periodontal disease of residual dentition
  • Need for pre-surgical bone or soft tissue augmentation in the planned implant area/s.
  • Absence of occlusal stability in centric occlusion
  • Any systemic or local disease or condition that would compromise post-operative healing and/or osseointegration
  • Systemic or any other medication that would compromise post-operative healing and/or osseointegration
  • Pregnancy
  • Present alcohol or drug abuse
  • Tobacco smoking during the last 6 months
  • Unable or unwilling to return for follow-up visits for a period of 3 years
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    ASTRA TECH Implant System; Fixture ST

    Ø 4.5 cm in lengths 9-13 mm

    Device: ASTRA TECH Implant System; Fixture ST: Ø 4.5 cm in lengths of 9, 11 and 13 mm.

  • Experimental
    Biomet 3i; Osseotite® Implants

    Ø 4.0 cm in lengths 8.5-13 mm

    Device: 3i Osseotite® implant: Ø 4.0 in lengths of 8.5, 10, 11.5 and 13 mm

Interventions

  • DeviceASTRA TECH Implant System; Fixture ST: Ø 4.5 cm in lengths of 9, 11 and 13 mm.
  • Device3i Osseotite® implant: Ø 4.0 in lengths of 8.5, 10, 11.5 and 13 mm
06

What researchers measure

Primary outcomes

  1. Marginal Bone Level Changes

    Marginal bone adaptation was expressed as the distance from the implant reference point to the most coronal bone-to-implant contact on the mesial and distal side of the implant. Bone adaptation in millimeters at the 3-year follow-up visit were compared to values obtained at Implant placement (baseline). Positive value indicates bone gain and negative value bone loss.

    Time frame: 3 years after implant placement (baseline)

07

Results

Posted Apr 16, 2014

Participant flow

Participant flow — Overall Study
MilestoneASTRA TECH Implant System; Fixture STBiomet 3i; Osseotite® Implants
Started1818
Completed1516
Not completed32

Outcome measures

PrimaryMarginal Bone Level Changes

Marginal bone adaptation was expressed as the distance from the implant reference point to the most coronal bone-to-implant contact on the mesial and distal side of the implant. Bone adaptation in millimeters at the 3-year follow-up visit were compared to values obtained at Implant placement (baseline). Positive value indicates bone gain and negative value bone loss.

Time frame:
3 years after implant placement (baseline)
Reported as:
Mean · millimeter
Marginal Bone Level Changes
millimeterASTRA TECH Implant System; Fixture STBiomet 3i; Osseotite® Implants
Marginal Bone Level Changes-0.25 ± 0.60-0.50 ± 0.93

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
ASTRA TECH Implant System; Fixture ST—1/18 (5.6%)0/18 (0%)
Biomet 3i; Osseotite® Implants—1/18 (5.6%)0/18 (0%)
Most frequent serious events
Most frequent serious events
EventASTRA TECH Implant System; Fixture STBiomet 3i; Osseotite® Implants
Advanced breast cancerReproductive system and breast disorders0/181/18
Prostate cancerReproductive system and breast disorders1/180/18

Baseline characteristics

Age, Continuous
Age, Continuous(years)ASTRA TECH Implant System; Fixture STBiomet 3i; Osseotite® ImplantsTotal
Mean55 ± 1251 ± 1153 ± 12
Sex: Female, Male
Sex: Female, Male(Participants)ASTRA TECH Implant System; Fixture STBiomet 3i; Osseotite® ImplantsTotal
Female111223
Male7613
08

Study locations

2 sites
  • Dept. of Implant Dentistry, New York University
    New York, New York 10010, United States
  • Dept. of Prosthodontics, School of Dentistry, University of North Carolina
    Chapel Hill, North Carolina 27599-7450, United States
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2002, a primary completion of Jun 2011 and a completion of Jun 2011. It does not say whether these dates are actual or estimated.

Results were first posted in Apr 2014, 2 years 10 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2008
First posted
Sep 3, 2008
Start
Dec 2002
Primary completionActual
Jun 2011
CompletionActual
Jun 2011
Results first posted
Apr 16, 2014
Last update
Apr 13, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 13, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00746187
Responsible party
Sponsor
First posted
Sep 3, 2008
Start date
Dec 2002
Primary completion
Jun 2011
Completion
Jun 2011
Results posted
Apr 16, 2014
Last update
Apr 13, 2016

Study contacts

Dennis P Tarnow, D.D.S. Prof.
principal investigator · Dept. of Implant Dentistry, New York University (to March 2011)
Stuart Froum, Dr
principal investigator · Dept. of Implant Dentistry, New York University (from March 2011)

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion